Page last updated: 2024-10-26

etidronate and Hospital-Acquired Condition

etidronate has been researched along with Hospital-Acquired Condition in 2 studies

Etidronic Acid: A diphosphonate which affects calcium metabolism. It inhibits ectopic calcification and slows down bone resorption and bone turnover.
etidronic acid : A 1,1-bis(phosphonic acid) that is (ethane-1,1-diyl)bis(phosphonic acid) having a hydroxy substituent at the 1-position. It inhibits the formation, growth, and dissolution of hydroxyapatite crystals by chemisorption to calcium phosphate surfaces.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vestergaard, P1
Schwartz, K1
Pinholt, EM1
Rejnmark, L1
Mosekilde, L1
Hoppé, E1
Masson, C1
Laffitte, A1
Chappard, D1
Audran, M1

Other Studies

2 other studies available for etidronate and Hospital-Acquired Condition

ArticleYear
Gastric and esophagus events before and during treatment of osteoporosis.
    Calcified tissue international, 2010, Volume: 86, Issue:2

    Topics: Aged; Aged, 80 and over; Bone Density Conservation Agents; Case-Control Studies; Causality; Clodroni

2010
Osteomalacia in a patient with Paget's bone disease treated with long-term etidronate.
    Morphologie : bulletin de l'Association des anatomistes, 2012, Volume: 96, Issue:313

    Topics: Aged, 80 and over; Alkaline Phosphatase; Biopsy; Bone Density Conservation Agents; Calcification, Ph

2012